• News & Events
  • Talent Development
  • Talent Concept
  • Career Opportunity
  • Employee Life
  • Contact Us
  • 中文版
    Lakestar PharmaTech

    雷竞技网页版本-雷竞技raybet-雷竞技官网网页版 is a Sino-US joint venture, located at the beautiful Suzhou bay area of Lake Taihu, about 45 miles west of Shanghai. Since established in 2009, the company provides CRO and CDMO services in the small molecule synthesis area for pharmaceutical and bio-tech companies worldwide. Communication, Quality, and Technology are the three key attributes to Lakestar's growth and customer satisfaction.

    So far, Lakestar has applied more than 30 patents for innovations, and was awarded by the Chinese Ministry of Science and Technology a national grant for conducting process innovation of a blockbuster drug…

  • 0+
    In business for more than 13 years
  • 0+
    Applied more than 30 Patents
  • 0+
    Produced more than 500 drug intermediates
  • 0+
    Developed more than 100 API manufacturing processes
  • R&D Team

    Lakestar has a well experienced, technologically capable R&D team in Suzhou. Few leaders of the R&D team are elite scientists returned from overseas. They have worked many years in the global pharmaceutical industry, as well as the CRO and CDMO businesses.
  • Production Technology

    Lakestar has two manufacturing facilities. One is in Anqing, Anhui Province, and the other is in Zhoukou, Henan Province. We have a total of 100 reactors of glass-lined or stainless steel, in the size of 1000 to 8000 liters, operating at -10 to 150°C. Besides, we have 5 cryogenic reactors (1000-3000 liters), and can conduct reactions even at negative 100°C.
  • Recognition and Honor

    Applied more than 30 patents 

    Awarded a national grant by the Ministry of Science and Technology for innovating the manufacturing process of Blockbuster Drug 

    Received recognitions by the Government as the “Service Enterprise with Technological Excellence” and"National High-Tech Enterprise”